Ads
related to: renal cell carcinoma- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- Patient Resources
Find Patient Resources
On The Official Site.
- How This Treatment Works
Search results
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Zacks via Yahoo Finance· 3 days agoIovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for...
New PET agent provides same-day imaging for clear cell renal cell carcinoma patients
Medical Xpress· 5 days agoA novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of ...
Massive study identifies new biomarkers for renal cancer subtypes, improving diagnosis...
Medical Xpress· 7 days agoThe findings lay the groundwork to identify therapeutic targets in non-clear-cell renal cell carcinomas. Renal < ...
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Motley Fool via Yahoo Finance· 15 hours agoExelixis Exelixis specializes in cancer medicines. It earned quite a reputation thanks to its most...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 7 days agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
Leads Biolabs is Proud to Announce its Participation in the 2024 ASCO Annual Meeting with One Oral...
CBS 47 Fresno· 5 hours agoThe 2024 American Society of Clinical Oncology (ASCO) Annual Meeting will be held in Chicago from May 31 to June 4, 2024. Leads Biolabs will present the exciting clinical data on its four innovative clinical programs at the ASCO meeting.
YOUR HEALTH: Why some kidney cancer patients are living longer
WAFB Baton Rouge· 5 days agoKidney cancer is among the 10 most common cancers in both men and women. A decade ago, advanced...
AbCellera Biologics (ABCL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 5 days agoWe'd also like to congratulate ArsenalBio, who in April announced the first patient dosed in a Phase...
Q2 2024 EPS Estimates for Janux Therapeutics, Inc. Raised by Wedbush (NASDAQ:JANX)
ETF DAILY NEWS· 6 hours agoJanux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Equities research analysts at Wedbush upped their Q2 2024 EPS estimates for Janux Therapeutics in a research note issued on Wednesday, ...
Good to Know: Grim diagnosis spurs Kent couple to sell possessions, plan RV trip of a lifetime
Akron Beacon Journal via Yahoo News· 7 days agoBut a scan last summer found new growth and Dailey had surgery to remove tumors on the kidney. And...
Ad
related to: renal cell carcinoma